Academic conferences

Publications

Presentations

Providing Antiretroviral therapy in a Resource Limited Setting: Two year experience of an HIV Disease Management Programme in South Africa

Regensberg L, Pead C, Hislop M, Maartens G. Providing Antiretroviral therapy in a Resource Limited Setting: Two year experience of an HIV Disease Management Programme in South Africa. 13th World AIDS Conference, Durban 2000.

HIV/AIDS in seniors: Four years experience in providing access to antiretroviral therapy (ART) to older adults in a managed healthcare setting

Hislop M, Regensberg L. HIV/AIDS in seniors: Four years experience in providing access to antiretroviral therapy (ART) to older adults in a managed healthcare setting. Geriatrix Africa Conference, Cape Town, March 2003.

Home vs. Self-initiated art refill: clinical, immunological, and virologic outcomes

R. Leisegang, J. Ball, M. Cotton, D. Dowdy, K. Calkins, S. Cleary, G. Maartens, J. Nchega. Home vs. Self-initiated art refill: clinical, immunological, and virologic outcomes. 26th Conference on Retroviruses and Opportunistic Infections (CROI), Seattle, Washington, USA, 4 – 7 March 2019.

Optimizing tools for measuring short-term antiretroviral adherence from pharmacy refill data to predict virologic outcomes in resource limited settings

Leisegang R, McMahon J, Little F, Elliott J, Hislop M, Maartens G. Optimizing tools for measuring short-term antiretroviral adherence from pharmacy refill data to predict virologic outcomes in resource limited settings. 8th International AIDS Society Conference, Vancouver, Canada, 19 – 22 July 2015.

A Clinical Prediction Rule for PI resistance in resource limited settings

Cohen K, Stewart A, Kengne AP, Leisegang R, Coetsee M, Maharaj S, Dunn L, Hislop M, Regensberg L, Meintjes G, van Zyl G, Maartens G. A Clinical Prediction Rule for PI resistance in resource limited settings. 22nd Conference on Retroviruses and Opportunistic Infections (CROI), Seattle, Washington, USA, 23 – 26 February 2015.

Determinants of resistance to second-line protease inhibitor-based antiretroviral therapy in the Southern African private sector

Cohen K, Stewart A, Leisegang R, Coetsee M, Maharaj S, Dunn L, Hislop M, Regensberg L, Meintjes G, van Zyl G, Maartens G. Determinants of resistance to second-line protease inhibitor-based antiretroviral therapy in the Southern African private sector. South African HIV Clinicians Society Conference, Cape Town, September 2014.

Efficacy of third line ART in Africa: outcomes on ART salvage regimens in the Southern African private sector

Dunn L, Coetsee M, Hislop M, Regensberg L, Maartens G, Meintjes G. Efficacy of third line ART in Africa: outcomes on ART salvage regimens in the Southern African private sector. 7th European & Developing Countries Clinical Trials Partnership (EDCTP) Forum, Berlin, 1 July 2014.

A current review of the insurability and survival of lives living with HIV and other chronic disease

Sarkin L, Leisegang R. A current review of the insurability and survival of lives living with HIV and other chronic disease. 30th International Congress of Actuaries 2014, Washington, D.C., United States, 30 March – 4 April 2014.

Virological response to antiretroviral salvage therapy in the Southern African private sector

Dunn L, Coetsee M, Regensberg L, Hislop M, Maartens G, Meintjes G. Virological response to antiretroviral salvage therapy in the Southern African private sector. South African HIV Clinicians Society Conference, Cape Town, November 2012.

The impact of pregnancy on adherence to and defaulting from antiretroviral therapy

R Leisegang, J Nachega, M Hislop, and G Maartens. The impact of pregnancy on adherence to and defaulting from antiretroviral therapy. 18th Conference on Retroviruses and Opportunistic Infections (CROI), Boston, Massachusetts, USA February 27-Mar 2, 2011.